The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis
Abstract Background and aims: The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and Europe independently. Methods: Searches were conducted in PubMed, PsycINFO and Web of Science on 25 March 2025. A total of 43 studies (48 distinct samples;
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
